Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.044 | 0.7 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.058 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |